Stay updated on Remibrutinib Long-term Extension in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Remibrutinib Long-term Extension in Urticaria Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Expanded the Locations section to include numerous individual trial sites across the US, Argentina, Canada, Europe, Asia, and other regions, replacing the prior grouped location entries.
    Difference
    3%
    Check dated 2025-12-23T20:48:17.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 removed; no core content, trial data, or navigational functionality were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:42:48.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removal of the generic government funding/status banner from the page; this does not affect study details, eligibility criteria, or location information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T06:55:07.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Administrative updates were added to the study record, including Certification/Extension entries and updated last update timestamps. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:00:23.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Update includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:38:02.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Added a new revision tag v3.1.0 and removed several related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the earlier version tag v3.0.2. The net effect is updating versioning while trimming older related topics from the page.
    Difference
    0.3%
    Check dated 2025-09-29T03:07:39.000Z thumbnail image

Stay in the know with updates to Remibrutinib Long-term Extension in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.